Keyphrases
Bayesian Probability
14%
Celecoxib
42%
Change from Baseline
14%
Clinically Meaningful Improvement
14%
Confidence Interval
14%
Galcanezumab
100%
Interim Analysis
28%
Knee Osteoarthritis
100%
Knee Pain
28%
McMaster University
14%
Migraine
14%
Moderate to Severe
14%
Monoclonal Antibody
14%
Non-associated
100%
Osteoarthritis
42%
Osteoarthritis Pain
14%
Patient Global Assessment
14%
Placebo
100%
Posterior Probability
28%
Probability of Superiority
42%
Randomized Clinical Trial
100%
Study Identification
14%
Success Criteria
14%
Tolerability
14%
Visual Analog Scale
14%
Western Ontario
14%
WOMAC
42%
Medicine and Dentistry
Arm
14%
Calcitonin Gene Related Peptide
100%
Celecoxib
42%
Galcanezumab
100%
Interim Analysis
28%
Knee Osteoarthritis
100%
Knee Pain
28%
Migraine
14%
Monoclonal Antibody
14%
Osteoarthritis
71%
Physical Disease by Body Function
100%
Placebo
100%
Randomized Clinical Trial
100%
Visual Analog Scale
14%
Western Ontario and McMaster Universities Osteoarthritis Index
57%
Pharmacology, Toxicology and Pharmaceutical Science
Calcitonin Gene Related Peptide
100%
Celecoxib
42%
Galcanezumab
100%
Knee Osteoarthritis
100%
Knee Pain
28%
Migraine
14%
Monoclonal Antibody
14%
Osteoarthritis
85%
Physical Disease by Body Function
100%
Placebo
100%
Randomized Clinical Trial
100%
Tolerability
14%